| Literature DB >> 28619197 |
Panpan Hao1, Fan Jiang2, Jing Cheng1, Lianyue Ma1, Yun Zhang3, Yuxia Zhao4.
Abstract
Traditional Chinese medicine (TCM) has more than 2,000 years of history and has gained widespread clinical applications. However, the explicit role of TCM in preventing and treating cardiovascular disease remains unclear due to a lack of sound scientific evidence. Currently available randomized controlled trials on TCM are flawed, with small sample sizes and diverse outcomes, making it difficult to draw definite conclusions about the actual benefits and harms of TCM. Here, we systematically assessed the efficacy and safety of TCM for cardiovascular disease, as well as the pharmacological effects of active TCM ingredients on the cardiovascular system and potential mechanisms. Results indicate that TCM might be used as a complementary and alternative approach to the primary and secondary prevention of cardiovascular disease. However, further rigorously designed randomized controlled trials are warranted to assess the effect of TCM on long-term hard endpoints in patients with cardiovascular disease.Entities:
Keywords: Chinese herbal drugs; dyslipidemia; heart failure; hypertension; randomized controlled trials as topic; type 2 diabetes mellitus
Mesh:
Substances:
Year: 2017 PMID: 28619197 DOI: 10.1016/j.jacc.2017.04.041
Source DB: PubMed Journal: J Am Coll Cardiol ISSN: 0735-1097 Impact factor: 24.094